Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Revolution Medicines

Explore full profile

Targeted therapies for previously undruggable RAS-addicted cancers

Redwood City, United StatesFounded 2015Biotech & Life Sciences
Valuation $38B Market cap · Aug/2026
Revenue $103M Latest reported FY

At a glance

Status
Listed
Founded
2015
Headquarters
Redwood City, United States
Listing
IPO 2020
Sector
Biotech & Life Sciences
Power Law
Decacorn$10B+ valuation tier

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later8 investors entered at this stage

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Redwood City HQ
Book a demo for the full country breakdown
Web traffic by country
160K monthly visits
across markets
🇺🇸 United States49.6%
🇬🇧 United Kingdom6.5%
🇮🇳 India5.6%
🇨🇦 Canada5.1%
🇨🇭 Switzerland2.9%
Top 5 markets shown

Patents

Estimated portfolio value
$68M

86 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Revolution Medicines was the backer or acquirer, 2018–2023. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

2 deals across Revolution Medicines's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Revolution Medicines's portfolio, mapped.

        Stage
        Period
        2 of 2 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Revolution Medicines on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Revolution Medicines on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles